INB/ELIXIR-ES nodes and TransBioNet members effort on Covid-19 research is a collection of databases, public repositories, tools, scientific publications, consortia and research projects of the INB/ELIXIR-ES nodes and TransBioNet members across Spain supporting global SARS-CoV-2 and Covid-19 research and knowledge. In the webpage the following information/links are available and it is updated frequently: DATABASES and…
ELIXIR provides a range of services that can be used for studying the SARS-CoV-2 coronavirus and the Covid-19 disease. The webpage listed the following topics and it is constantly updated: Access data relevant to COVID-19 Make your data easier to find and share Find software and workflows to analyse your data Find computing resources to…
As part of its health threat plan activated to fight COVID-19, the Agency has finalised and published the composition and objectives of its COVID-19 EMA pandemic Task Force (COVID-ETF), which assists Member States and the European Commission in dealing with development, authorisation and safety monitoring of therapeutics and vaccines intended for treatment or prevention of COVID-19. The main…
The young scientists’ prize award by SciLifeLab together with Science/AAAS – the Science & SciLifeLab Prize for Young Scientists is now open for applications! Four recent PhDs are selected as winners and will be published by Science, receive up to 30,000 USD and be invited to Sweden to receive their awards, present their research, and…
The EU has opened yesterday #2 important calls. Info and details are listed here. Individual Fellowships: MSCA-H2020-IF-2020 Objective. The goal of the Individual Fellowships is to enhance the creative and innovative potential of experienced researchers, wishing to diversify their individual competence in terms of skill acquisition through advanced training, international and intersectoral mobility. Individual Fellowships…
What can biobanks do against COVID-19? Taking care of today’s COVID-19 patients is priority number 1. Researchers will need high quality samples from patients and healthy controls, collected in clinical settings and in an ethical way. BBMRI-ERIC can all help with that. In the past weeks, BBRMI collected information on the resources national nodes and…
The GA4GH meeting was online due to the Covid-19 outbreak. The level of participation and engagement of participants coming from different geographical locations have motivated the organizers to develop resources and materials collected during the virtual meeting and make them available to everyone. Here are the links to view the Meeting Reports on the website…
There is no anti-Covid-19 drug globally accepted for treatment, but many drugs are under investigations. About 16 trials of antivirals are under development (6 march 2020). Antiviral drugs are difficult to find, because of the cell-parasitic nature of viruses. It has been long to get efficient drugs against HIV or Hepatitis C. COVID-19 vaccine may…
EURORDIS has launched a new contribution on ERNs and health data to trigger a strategic discussion on health data and ERNs that will allow the Networks to have a long-term strategy that is aligned with their needs and ambition. The proposal aims to progress towards developing a comprehensive ERN data strategy that is structured around…
Global research and innovation forum: towards a research roadmap The World Health Organization (WHO) has recently developed and launched this official document to Powering research to control the epidemic. Broad consensus on the need for research to focus on actions that can save lives now. To ensure that those affected are promptly diagnosed and receive…